Product Information
LAMIVUDINE HBV 100 MG TABLET is a generic product labeled by Apotex Corp., priced at $9.6988 per EA under NDC 60505325006. Its NADAC has been published 607 times since Apr 23, 2014.
Strength
100 mg/1
Manufacturer
Apotex Corp.NDC
60505325006
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA202941On Market Since
1/3/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE HBV 100 MG TABLET has been published 607 times since Apr 23, 2014, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6988 per EA |
|---|---|
| All-time high | $11.2082 (Nov 12, 2014) |
| All-time low | $1.5548 (May 17, 2023) |
| 52-week high | $9.6988 |
| 52-week low | $8.6264 |
| Median price | $4.2718 |
| Average price | $5.3457 |
| Largest weekly change | +160.1% (Sep 18, 2024) |
| Weeks tracked | 607 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE HBV 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE HBV 100 MG TABLET, manufactured by Apotex Corp., is $9.6988 per EA (NDC 60505325006), effective Jun 24, 2026.
How has the price of LAMIVUDINE HBV 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE HBV 100 MG TABLET has declined 9.6%. It has been tracked across 607 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE HBV 100 MG TABLET?
Since Apr 23, 2014, the NADAC for LAMIVUDINE HBV 100 MG TABLET has ranged from a low of $1.5548 (May 17, 2023) to a high of $11.2082 (Nov 12, 2014), with a median of $4.2718 per EA.
Are there cheaper alternatives to LAMIVUDINE HBV 100 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LAMIVUDINE HBV 100 MG TABLET, is $8.1597 per EA — about 16% below LAMIVUDINE HBV 100 MG TABLET.
Who manufactures LAMIVUDINE HBV 100 MG TABLET?
LAMIVUDINE HBV 100 MG TABLET (NDC 60505325006) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification